Author

Haggai Bar-Yoseph

The future of microbiome therapeutics
The future of microbiome therapeutics

Haggai Bar-Yoseph

THE ASSOCIATION BETWEEN LOW BODY-MASS INDEX AND SERIOUS POST-ENDOSCOPIC ADVERSE EVENTS
THE ASSOCIATION BETWEEN LOW BODY-MASS INDEX AND SERIOUS POST-ENDOSCOPIC ADVERSE EVENTS

INTRODUCTION OF THE PROBIOTIC STRAIN, E COLI NISSLE 1917, REDUCES MICROBIAL DIVERSITY, PARTIALLY MEDIATED BY HOST-ACTIVATED TYPE VI SECRETION SYSTEM
INTRODUCTION OF THE PROBIOTIC STRAIN, E COLI NISSLE 1917, REDUCES MICROBIAL DIVERSITY, PARTIALLY MEDIATED BY HOST-ACTIVATED TYPE VI SECRETION SYSTEM

MICROBIOME CHANGES UNDER NUTRIENT DEPRIVATION ARE DYNAMIC AND DEPENDENT ON INTESTINAL LOCATION
MICROBIOME CHANGES UNDER NUTRIENT DEPRIVATION ARE DYNAMIC AND DEPENDENT ON INTESTINAL LOCATION

Haggai Bar-Yoseph  et al.

INTRODUCTION OF THE PROBIOTIC STRAIN, E COLI NISSLE 1917, REDUCES MICROBIAL DIVERSITY, PARTIALLY MEDIATED BY HOST-ACTIVATED TYPE VI SECRETION SYSTEM
INTRODUCTION OF THE PROBIOTIC STRAIN, E COLI NISSLE 1917, REDUCES MICROBIAL DIVERSITY, PARTIALLY MEDIATED BY HOST-ACTIVATED TYPE VI SECRETION SYSTEM

Haggai Bar-Yoseph  et al.

LOW DRUG LEVELS ARE IMMUNOGENIC:EXCESS INFLIXIMAB COMPETES WITH IFX/TNF COMPLEXES TO DECREASE COMPLEX-INDUCED IMMUNOGENICITY
LOW DRUG LEVELS ARE IMMUNOGENIC:EXCESS INFLIXIMAB COMPETES WITH IFX/TNF COMPLEXES TO DECREASE COMPLEX-INDUCED IMMUNOGENICITY

Haggai Bar-Yoseph  et al.

THE ASSOCIATION BETWEEN LOW BODY-MASS INDEX AND SERIOUS POST-ENDOSCOPIC ADVERSE EVENTS
THE ASSOCIATION BETWEEN LOW BODY-MASS INDEX AND SERIOUS POST-ENDOSCOPIC ADVERSE EVENTS

Haggai Bar-Yoseph  et al.

REDUCED TREATMENT ESCALATION IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH DIABETES MELLITUS USING NEWER ANTI-DIABETIC MEDICATIONS: AN ANALYSIS FROM THE EPI-IIRN
REDUCED TREATMENT ESCALATION IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH DIABETES MELLITUS USING NEWER ANTI-DIABETIC MEDICATIONS: AN ANALYSIS FROM THE EPI-IIRN

Haggai Bar-Yoseph  et al.

ASSOCIATION OF ANTIBIOTIC USE WITH DURABILITY OF BIOLOGIC AGENTS IN INFLAMMATORY BOWEL DISEASE: A REPORT FROM THE EPI-IIRN
ASSOCIATION OF ANTIBIOTIC USE WITH DURABILITY OF BIOLOGIC AGENTS IN INFLAMMATORY BOWEL DISEASE: A REPORT FROM THE EPI-IIRN

Haggai Bar-Yoseph  et al.

Item 1 - 9 / 9
1